Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp's Monogram Acquisition Clears Antitrust Review

NEW YORK (GenomeWeb News) – Laboratory Corporation of America's $107 million acquisition of Monogram Biosciences has cleared US antitrust review, the clinical lab giant said today.

Under the deal announced last month, LabCorp will acquire all of the outstanding shares of Monogram in a cash offer of $4.55 per share for a total equity value of $106.7 million. The acquisition price represented a significant premium over Monogram's closing price of $1.68 on the Nasdaq the day before the acquisition was announced.

The tender offer is scheduled to expire at the end of the day on July 29, unless it is extended. The firms previously said that they hope to close the acquisition during the third quarter.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.